Zymeworks ZYME
NASDAQ ZYME
$29.42 -0.48 (-1.61%)
As of: Sep 4, 2026 · 1:35 PM EDT

Zymeworks (ZYME) Profit After Tax (2021 - 2026)

Zymeworks (ZYME) posted Profit After Tax of -$486000.0 for Q1 2026, up 99.41% sequentially from -$82.0 million in Q4 2025, and up 97.8% YoY from -$245702.8 in Q1 2025.

Analysis

Zymeworks (ZYME) Profit After Tax (2021 - 2026) Analysis & Trends

Zymeworks has reported Profit After Tax for 6 years, with the latest figure at -$486000.0 in Q1 2026.

  • Quarterly Profit After Tax rose 97.8% year-over-year to -$486000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$102.1 million (up 29.14% YoY) and the FY2025 annual result came in at -$81.1 million, up 34.06% from the prior year.
  • Profit After Tax climbed to -$486000.0 in Q1 2026 per ZYME's latest filing, from -$82.0 million in the prior quarter.
  • Over five years, Profit After Tax peaked at $309.4 million in Q4 2022 and troughed at -$123.6 million in Q4 2024.
  • A 5-year average of -$12.1 million and a median of -$1.5 million in 2023 frame the typical range for Profit After Tax.
  • The sharpest annual moves came in 2024 and 2025: Profit After Tax surged 492.78% in 2024, then tumbled 1870.56% in 2025.
  • Over 5 years, Profit After Tax stood at $309.4 million in 2022, then plunged by 137.82% to -$117.0 million in 2023, then decreased by 5.65% to -$123.6 million in 2024, then surged by 33.66% to -$82.0 million in 2025, then surged by 99.41% to -$486000.0 in 2026.
  • According to Business Quant data, Profit After Tax over the past three periods registered -$486000.0, -$82.0 million, and -$19.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Vertex Pharmaceuticals 139.31 Bn 131.46 Bn 2.84 Bn 1.10 Bn
2 Regeneron Pharmaceuticals 85.65 Bn 77.66 Bn 3.93 Bn 1.30 Bn
3 Argenx Se 63.46 Bn 58.27 Bn 1.37 Bn 472.00 Mn
4 Moderna 57.94 Bn 52.80 Bn 52.00 Mn -782.00 Mn
5 Revolution Medicines 44.05 Bn 44.05 Bn - -644.37 Mn
6 BeOne Medicines 39.96 Bn 34.86 Bn 1.53 Bn 237.01 Mn
7 Alnylam Pharmaceuticals 35.16 Bn 31.85 Bn 992.69 Mn 164.49 Mn
8 Royalty Pharma 28.44 Bn 27.60 Bn - 81.49 Mn
9 Insmed 27.32 Bn 26.16 Bn 358.27 Mn -16.62 Mn
10 Zymeworks 2.15 Bn 1.88 Bn - -45.15 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -45.15 Mn
Mar 31, 2026 -44.16 Mn
Dec 31, 2025 -41.21 Mn
Sep 30, 2025 -19.60 Mn
Jun 30, 2025 2.38 Mn
Mar 31, 2025 -22.64 Mn
Dec 31, 2024 -23.86 Mn
Sep 30, 2024 -29.85 Mn
Jun 30, 2024 -37.69 Mn
Mar 31, 2024 -31.65 Mn
Dec 31, 2023 -12.84 Mn
Sep 30, 2023 -29.17 Mn
Jun 30, 2023 -51.15 Mn
Mar 31, 2023 -24.35 Mn
Dec 31, 2022 309.43 Mn
Sep 30, 2022 -47.85 Mn
Jun 30, 2022 -64.62 Mn
Mar 31, 2022 -72.63 Mn
Dec 31, 2021 -39.15 Mn
Sep 30, 2021 -60.58 Mn